The Porter Law Group is currently pursuing a significant medical malpractice settlement in a case involving a devastating delay in prostate cancer diagnosis that has dramatically impacted the patient’s survival chances. The case centers around a healthcare provider’s failure to properly address and follow up on critically abnormal PSA test results, leading to a 15-month delay in cancer diagnosis and treatment.
Connect with us for a non-obligatory free consultation.
In September 2020, the client underwent routine PSA testing, which revealed an alarming value of 6.99 – a significant increase from his previous reading of 3.34 just ten months earlier. Despite this concerning change, the medical team failed to notify the client of these results or explain their significance. The oversight continued during a follow-up visit in January 2021, where the abnormal PSA value was again not addressed or discussed.
The consequences of this delay proved devastating. When the client was finally referred to a urologist in September 2021, his PSA levels had skyrocketed to 24.61. Subsequent testing confirmed the presence of Stage IVA prostate adenocarcinoma with metastasis to multiple lymph nodes. The tragedy of this case lies in the medical experts’ assessment that with timely intervention in 2020, the cancer would likely have been contained within the prostate capsule and potentially curable.
The impact on the client’s life has been profound. Once an active outdoorsman who maintained eight acres of property, including two ponds, he now struggles with constant fatigue and weakness. His ability to care for his home and property has been severely compromised. Perhaps most devastating is the effect on his family relationships – he can no longer be intimate with his wife due to the effects of treatment, and his two daughters have had to transition from being children to caregivers.
Medical experts retained by the Porter Law Group are prepared to testify that the 15-month delay in diagnosis and treatment has dramatically reduced the client’s survival prospects. While early detection would have offered an excellent prognosis, the client’s five-year survival rate is now estimated at just 31 percent.
The case is particularly compelling due to the treating physician’s own acknowledgment of the oversight. In a December 2021 medical note, the doctor wrote, “In retrospect, I sincerely wish that he had been seen by Urology last year when his PSA was 6.9 in September 2020” – a statement that essentially admits to the failure in standard of care.
The settlement demand of $4.3 million reflects not only the severe physical and emotional suffering endured by the client but also accounts for substantial economic damages. These include over $173,000 in lost household services, significant past medical expenses totaling nearly $35,000, and anticipated future medical costs requiring a Medicare set-aside account.
This case underscores the critical importance of proper PSA test monitoring and timely follow-up in prostate cancer diagnosis. For anyone who has experienced similar delays in cancer diagnosis or other serious medical conditions, it’s crucial to understand your legal rights. The Porter Law Group has extensive experience in medical malpractice cases and stands ready to evaluate potential claims and fight for just compensation for victims of medical negligence.
If you or a loved one has experienced a delayed diagnosis or other medical error, please don’t hesitate to reach out for a confidential consultation to discuss your options. Time limits apply to filing medical malpractice claims, so prompt action is essential to protect your rights.
